JPRN-UMIN000003149
Completed
未知
Clinical trial of CDP-choline for the patients with corticobasal degeneration - CDP-choline treatment for CBD patients
Tadanori Hamano0 sites15 target enrollmentFebruary 8, 2010
Conditionscoticobasal degeneration
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- coticobasal degeneration
- Sponsor
- Tadanori Hamano
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patients who showed allergy by previous CDP\-choline injection.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Efficacy and Safety of CDP-choline in Patients With Methamphetamine DependenceMethamphetamine DependenceNCT01007539Seoul National University Hospital31
Completed
Not Applicable
A Randomised Placebo Controlled Trial of a Cholinesterase Inhibitor in the Management of Agitation in Dementia that is Unresponsive to a Psychological InterventioISRCTN62185868King's College London (UK)285
Completed
Not Applicable
A Clinical trial of compound drugs for patients with type2 diabetes - Comparative analysis of the characteristics of postprandial hyperglycemia improving drugs for postprandial metabolic disorder.type2 diabetesJPRN-UMIN000006199Advanced Clinical Research Organization12
Recruiting
Phase 2
Phase-2 clinical trial on the treatment of chronic dysphagia in head and neck cancer patients with dedicated strengthening exercises using the Swallow Exercise AidDysphagiaswallowing impairment10027656NL-OMON42230Antoni van Leeuwenhoek Ziekenhuis20
Completed
Not Applicable
effect of Duloxetine in treatment of ADHDAttention Deficit Hyperactivity Disorder(ADHD).Attention deficit: disorder with hyperactivity hyperactivity disorder syndrome with hyperactivityIRCT2012072210363N1niversity of Social Welfare and Rehabilitation Sciences10